Drug Related Products: ProPhase Labs (NASDAQ:PRPH), Natural Alternatives International (NASDAQ:NAII), USANA Health Sciences (NYSE:USNA), Auxilium Pharmaceuticals (NASDAQ:AUXL)

ProPhase Labs Inc (NASDAQ:PRPH), announced their support of ESPN’s First Take host, Stephen A. Smith by directing its ad agency to increase advertising of its products on both ESPN and ESPN2. ProPhase Labs Inc (NASDAQ:PRPH), net profit margin is -3.00% and weekly performance is 1.24%. On last trading day company shares ended up $1.63. Analysts mean target price for the company is $15.55. ProPhase Labs Inc (NASDAQ:PRPH), distance from 50-day simple moving average (SMA50) is -11.69%.

Natural Alternatives International, Inc. (NASDAQ:NAII), fell 6.79% in last trading session and ended the day on $5.22. NAII, Gross Margin is 17.50% and its return on assets is 3.10%. Natural Alternatives International, Inc. (NASDAQ:NAII), quarterly performance is -2.43%.

USANA Health Sciences, Inc. (NYSE:USNA), Insider Dave Wentz sold 5,301 shares of USANA Health Sciences stock in a transaction that occurred on Friday, June 13th. The shares were sold at an average price of $75.51, for a total transaction of $400,278.51. Following the completion of the transaction, the insider now directly owns 473,955 shares of the company’s stock, valued at approximately $35,788,342. USANA Health Sciences, Inc. (NYSE:USNA), shares moved up 0.21% in last trading session and was closed at $77.20, while trading in range of $76.01 – 77.50. USANA Health Sciences, Inc. (NYSE:USNA), year to date (YTD) performance is 2.14%.

Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL), will take control of QLT in a transaction that will create a British Columbia-headquartered company called New Auxilium, in which existing Auxilium shareholders will own 76 per cent, and QLT shareholders will own 24 per cent. The deal allows Auxilium to take advantage of Canada’s lower corporate tax rates – a strategy that has been employed by other pharmaceutical companies looking to lower their tax rates in recent years. Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL), ended the last trading day at $20.69. Company weekly volatility is calculated as 4.60% and price to cash ratio as 13.58. Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL), showed a negative weekly performance of 5.27%.